Micro-Tech (Nanjing) (688029) Fundamentals 2026 — P/E 26.0x, Revenue Analysis | SniperIQ
Micro-Tech (Nanjing) (688029) is a CN-listed Healthcare company in Medical - Instruments & Supplies with a market capitalization of ¥14.4B, trading at ¥77.14 on the SHH. This SniperIQ fundamentals page covers Micro-Tech (Nanjing)'s valuation (P/E 26.0x, P/B 3.4x), profitability (net margin 16.6%), revenue (¥3.2B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Micro-Tech (Nanjing)'s market cap?
Micro-Tech (Nanjing) (688029) has a market capitalization of approximately ¥14.4B, trading at ¥77.14 on the SHH. Market cap moves with the live share price.
What is Micro-Tech (Nanjing)'s P/E ratio?
Micro-Tech (Nanjing)'s trailing twelve-month P/E ratio is 26.0x, with a price-to-book (P/B) of 3.4x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Micro-Tech (Nanjing)?
Micro-Tech (Nanjing) runs a net profit margin of 16.6%, a gross margin of 62.8%, and an operating margin of 20.8%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Micro-Tech (Nanjing) generate?
Micro-Tech (Nanjing) reported revenue of ¥3.2B for fiscal year 2025, with net income of ¥570M and earnings per share (EPS) of 3.05. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Micro-Tech (Nanjing) pay a dividend?
Micro-Tech (Nanjing) offers a trailing dividend yield of about 1.9%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Micro-Tech (Nanjing) financially healthy?
Micro-Tech (Nanjing) carries a debt-to-equity ratio of 0.01x and a current ratio of 4.27x, with a market beta of 0.28. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Micro-Tech (Nanjing) a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Micro-Tech (Nanjing) (688029) the key facts are: market cap ¥14.4B, P/E 26.0x, revenue ¥3.2B, 52-week range 65.7-101.61. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Micro-Tech (Nanjing)'s full fundamentals live
Get Micro-Tech (Nanjing)'s 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.